name,category,termsDnaJ (Hsp40) homolog, subfamily C, member 5 gamma,INTERPRO[450001438$IPR001623:Heat shock protein DnaJ, N-terminal, 450002720$IPR003095:Heat shock protein DnaJ, 450014048$IPR015609:Molecular chaperone, heat shock protein, Hsp40, DnaJ, 450016538$IPR018253:Heat shock protein DnaJ, conserved site]
DnaJ (Hsp40) homolog, subfamily C, member 5 gamma,SMART[760000243$SM00271:DnaJ]
DnaJ (Hsp40) homolog, subfamily C, member 5 gamma,SP_PIR_KEYWORDS[790000288$Chaperone, 790000356$complete proteome, 790000881$lipoprotein, 790000919$membrane, 790001100$palmitate, 790001162$phosphoprotein, 790001212$polymorphism]
DnaJ (Hsp40) homolog, subfamily C, member 5 gamma,UP_SEQ_FEATURE[850016184$chain:DnaJ homolog subfamily C member 5G, 850102480$compositionally biased region:Cys-rich, 850104487$domain:J, 850106258$modified residue, 850117295$sequence variant]
GDP dissociation inhibitor 1,INTERPRO[450000699$IPR000806:Rab GDI protein, 450001776$IPR002005:Rab GTPase activator, 450016490$IPR018203:GDP dissociation inhibitor]
GDP dissociation inhibitor 1,OMIM_DISEASE[520003198$Mental retardation, X-linked nonspecific]
GDP dissociation inhibitor 1,PIR_SUPERFAMILY[630016226$PIRSF019647:GDP dissociation inhibitor XAP-4]
GDP dissociation inhibitor 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000446$disease mutation, 790000640$GTPase activation, 790000930$mental retardation, 790001162$phosphoprotein]
GDP dissociation inhibitor 1,UP_SEQ_FEATURE[850056508$chain:Rab GDP dissociation inhibitor alpha, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
IQ motif containing D,INTERPRO[450000040$IPR000048:IQ calmodulin-binding region]
IQ motif containing D,SMART[760000009$SM00015:IQ]
IQ motif containing D,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
IQ motif containing D,UP_SEQ_FEATURE[850026738$chain:IQ domain-containing protein D, 850104439$domain:IQ, 850117295$sequence variant, 850118574$splice variant]
RAB interacting factor,INTERPRO[450006869$IPR007515:Mss4, 450010223$IPR011323:Mss4/translationally controlled tumour-associated TCTP]
RAB interacting factor,PIR_SUPERFAMILY[630014986$PIRSF018365:guanine nucleotide exchange factor MSS4]
RAB interacting factor,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000641$guanine-nucleotide releasing factor, 790000937$metal-binding, 790001266$protein transport, 790001558$transport, 790001648$zinc]
RAB interacting factor,UP_SEQ_FEATURE[850022689$chain:Guanine nucleotide exchange factor MSS4, 850105852$helix, 850106218$metal ion-binding site:Zinc, 850106258$modified residue, 850117294$sequence conflict, 850118575$strand, 850118624$turn]
XK, Kell blood group complex subunit-related, X-linked,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
XK, Kell blood group complex subunit-related, X-linked,UP_SEQ_FEATURE[850101015$chain:XK-related protein 2, 850117294$sequence conflict, 850118574$splice variant, 850118623$transmembrane region]
ankyrin repeat and SOCS box-containing 1,INTERPRO[450001330$IPR001496:SOCS protein, C-terminal, 450001870$IPR002110:Ankyrin]
ankyrin repeat and SOCS box-containing 1,SMART[760000220$SM00248:ANK, 760000225$SM00253:SOCS]
ankyrin repeat and SOCS box-containing 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000086$ank repeat, 790000356$complete proteome, 790000428$developmental protein, 790001304$repeat, 790001593$ubl conjugation pathway]
ankyrin repeat and SOCS box-containing 1,UP_SEQ_FEATURE[850005339$chain:Ankyrin repeat and SOCS box protein 1, 850105375$domain:SOCS box, 850106258$modified residue, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850115656$repeat:ANK 5, 850115657$repeat:ANK 6]
ankyrin repeat domain 2 (stretch responsive muscle),INTERPRO[450001870$IPR002110:Ankyrin]
ankyrin repeat domain 2 (stretch responsive muscle),SMART[760000220$SM00248:ANK]
ankyrin repeat domain 2 (stretch responsive muscle),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000086$ank repeat, 790000244$cardiac muscle, 790000356$complete proteome, 790000646$heart, 790001212$polymorphism, 790001304$repeat, 790001415$skeletal muscle]
ankyrin repeat domain 2 (stretch responsive muscle),UP_SEQ_FEATURE[850005372$chain:Ankyrin repeat domain-containing protein 2, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850115656$repeat:ANK 5, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
calpain, small subunit 1,INTERPRO[450001814$IPR002048:Calcium-binding EF-hand, 450010817$IPR011992:EF-Hand type, 450016532$IPR018247:EF-HAND 1, 450016534$IPR018249:EF-HAND 2]
calpain, small subunit 1,SMART[760000046$SM00054:EFh]
calpain, small subunit 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000211$calcium, 790000212$calcium binding, 790000264$cell membrane, 790000356$complete proteome, 790000397$cysteine proteinase, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000473$duplication, 790000480$EF hand, 790000679$heterodimer, 790000743$hydrolase, 790000919$membrane, 790001212$polymorphism, 790001304$repeat]
calpain, small subunit 1,UP_SEQ_FEATURE[850000616$calcium-binding region:1, 850000622$calcium-binding region:2, 850000626$calcium-binding region:3, 850009167$chain:Calpain small subunit 1, 850102521$compositionally biased region:Gly-rich (hydrophobic), 850102573$compositionally biased region:Poly-Gly, 850102580$compositionally biased region:Poly-Pro, 850103581$domain:EF-hand 1; atypical, 850103583$domain:EF-hand 2, 850103585$domain:EF-hand 3, 850103587$domain:EF-hand 4, 850103588$domain:EF-hand 5, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
chromosome 7 open reading frame 36,INTERPRO[450017437$IPR019191:Essential protein Yae1, N-terminal]
chromosome 7 open reading frame 36,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 7 open reading frame 36,UP_SEQ_FEATURE[850074420$chain:Uncharacterized protein C7orf36, 850117294$sequence conflict, 850117295$sequence variant]
filamin B, beta (actin binding protein 278),INTERPRO[450001143$IPR001298:Filamin/ABP280 repeat, 450001411$IPR001589:Actinin-type, actin-binding, conserved site, 450001520$IPR001715:Calponin-like actin-binding, 450012396$IPR013783:Immunoglobulin-like fold, 450016187$IPR017868:Filamin/ABP280 repeat-like]
filamin B, beta (actin binding protein 278),KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038853$hsa04510:Focal adhesion]
filamin B, beta (actin binding protein 278),OMIM_DISEASE[520000426$Atelosteogenesis, type III, 520000427$Atelostogenesis, type I, 520000651$Boomerang dysplasia, 520002765$Larsen syndrome, 520002766$Larsen syndrome, autosomal dominant, 520002767$Larson syndrome, 520004651$Spondylocarpotarsal synostosis syndrome]
filamin B, beta (actin binding protein 278),SMART[760000025$SM00033:CH, 760000496$SM00557:IG_FLMN]
filamin B, beta (actin binding protein 278),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000019$actin-binding, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000428$developmental protein, 790000434$differentiation, 790000446$disease mutation, 790000474$dwarfism, 790001001$myogenesis, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
filamin B, beta (actin binding protein 278),UP_SEQ_FEATURE[850019486$chain:Filamin-B, 850103007$domain:Actin-binding, 850103318$domain:CH 1, 850103319$domain:CH 2, 850105852$helix, 850106258$modified residue, 850111881$region of interest:Hinge 1, 850111882$region of interest:Hinge 2, 850112323$region of interest:Interaction with FBLP1, 850112332$region of interest:Interaction with FLNA 1, 850112333$region of interest:Interaction with FLNA 2, 850112444$region of interest:Interaction with INPPL1, 850112924$region of interest:Interaction with the cytoplasmic tail of GP1BA, 850114627$region of interest:Self-association site, tail, 850115955$repeat:Filamin 1, 850115956$repeat:Filamin 10, 850115957$repeat:Filamin 11, 850115958$repeat:Filamin 12, 850115959$repeat:Filamin 13, 850115960$repeat:Filamin 14, 850115961$repeat:Filamin 15, 850115962$repeat:Filamin 16, 850115963$repeat:Filamin 17, 850115964$repeat:Filamin 18, 850115965$repeat:Filamin 19, 850115966$repeat:Filamin 2, 850115967$repeat:Filamin 20, 850115968$repeat:Filamin 21, 850115969$repeat:Filamin 22, 850115970$repeat:Filamin 23, 850115971$repeat:Filamin 24, 850115972$repeat:Filamin 3, 850115973$repeat:Filamin 4, 850115974$repeat:Filamin 5, 850115975$repeat:Filamin 6, 850115976$repeat:Filamin 7, 850115977$repeat:Filamin 8, 850115978$repeat:Filamin 9, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
fucosyltransferase 6 (alpha (1,3) fucosyltransferase),INTERPRO[450001336$IPR001503:Glycosyl transferase, family 10]
fucosyltransferase 6 (alpha (1,3) fucosyltransferase),KEGG_PATHWAY[470038784$hsa00601:Glycosphingolipid biosynthesis]
fucosyltransferase 6 (alpha (1,3) fucosyltransferase),OMIM_DISEASE[520001946$Fucosyltransferase-6 deficiency]
fucosyltransferase 6 (alpha (1,3) fucosyltransferase),PIR_SUPERFAMILY[630005650$PIRSF005726:fucosyltransferase]
fucosyltransferase 6 (alpha (1,3) fucosyltransferase),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000619$glycosyltransferase, 790000624$golgi apparatus, 790000691$hexosyltransferase, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
fucosyltransferase 6 (alpha (1,3) fucosyltransferase),UP_SEQ_FEATURE[850004581$chain:Alpha-(1,3)-fucosyltransferase, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
gap junction protein, alpha 10, 62kDa,INTERPRO[450000426$IPR000500:Connexins, 450011736$IPR013092:Connexin, N-terminal, 450016298$IPR017990:Connexin, conserved site, 450016299$IPR017991:Connexin region, 450017807$IPR019570:Gap junction protein, cysteine-rich domain]
gap junction protein, alpha 10, 62kDa,SMART[760000029$SM00037:CNX]
gap junction protein, alpha 10, 62kDa,SP_PIR_KEYWORDS[790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000581$gap junction, 790000919$membrane, 790001555$transmembrane]
gap junction protein, alpha 10, 62kDa,UP_SEQ_FEATURE[850020607$chain:Gap junction alpha-10 protein, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
guanylate binding protein 4,INTERPRO[450002808$IPR003191:Guanylate-binding protein, C-terminal, 450014315$IPR015894:Guanylate-binding protein, N-terminal]
guanylate binding protein 4,PIR_SUPERFAMILY[630005479$PIRSF005552:guanine nucleotide-binding protein 1]
guanylate binding protein 4,SP_PIR_KEYWORDS[790000012$acetylation, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000639$gtp-binding, 790001063$nucleotide-binding, 790001212$polymorphism]
guanylate binding protein 4,UP_SEQ_FEATURE[850022800$chain:Guanylate-binding protein 4, 850102585$compositionally biased region:Poly-Val, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850117294$sequence conflict, 850117295$sequence variant]
hydrocephalus inducing homolog 2 (mouse); hydrocephalus inducing homolog (mouse),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
hydrocephalus inducing homolog 2 (mouse); hydrocephalus inducing homolog (mouse),UP_SEQ_FEATURE[850025150$chain:Hydrocephalus-inducing protein homolog, 850102572$compositionally biased region:Poly-Glu, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand]
kelch-like 11 (Drosophila),INTERPRO[450000181$IPR000210:BTB/POZ-like, 450006067$IPR006652:Kelch repeat type 1, 450010229$IPR011333:BTB/POZ fold, 450010533$IPR011705:BTB/Kelch-associated, 450011722$IPR013069:BTB/POZ, 450011733$IPR013089:Kelch related, 450014332$IPR015915:Kelch-type beta propeller]
kelch-like 11 (Drosophila),SMART[760000197$SM00225:BTB, 760000541$SM00612:Kelch]
kelch-like 11 (Drosophila),SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000819$kelch repeat, 790001304$repeat, 790001363$Secreted, 790001405$signal]
kelch-like 11 (Drosophila),UP_SEQ_FEATURE[850027127$chain:Kelch-like protein 11, 850103083$domain:BACK, 850103177$domain:BTB, 850105852$helix, 850116239$repeat:Kelch 1, 850116250$repeat:Kelch 2, 850116251$repeat:Kelch 3, 850116252$repeat:Kelch 4, 850116253$repeat:Kelch 5, 850117814$signal peptide, 850118575$strand, 850118624$turn]
one cut homeobox 1,INTERPRO[450001200$IPR001356:Homeobox, 450002924$IPR003350:Homeodomain protein CUT, 450010997$IPR012287:Homeodomain-related, 450016278$IPR017970:Homeobox, conserved site]
one cut homeobox 1,KEGG_PATHWAY[470038889$hsa04950:Maturity onset diabetes of the young]
one cut homeobox 1,SMART[760000341$SM00389:HOX]
one cut homeobox 1,SP_PIR_KEYWORDS[790000020$activator, 790000356$complete proteome, 790000466$dna-binding, 790000699$Homeobox, 790001065$nucleus, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
one cut homeobox 1,UP_SEQ_FEATURE[850023518$chain:Hepatocyte nuclear factor 6, 850102574$compositionally biased region:Poly-His, 850102581$compositionally biased region:Poly-Ser, 850102906$DNA-binding region:CUT, 850102927$DNA-binding region:Homeobox, 850117294$sequence conflict, 850117295$sequence variant]
oxytocin, prepropeptide,INTERPRO[450000853$IPR000981:Neurohypophysial hormone, 450014644$IPR016321:Nonapeptide hormone precursor]
oxytocin, prepropeptide,PIR_SUPERFAMILY[630001952$PIRSF001815:nonapeptide hormone precursor, 630001953$PIRSF001815:Nonapeptide_hormone_precursor]
oxytocin, prepropeptide,SMART[760000002$SM00003:NH]
oxytocin, prepropeptide,SP_PIR_KEYWORDS[790000059$amidated carboxyl end, 790000060$amidation, 790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000708$hormone, 790000834$lactation, 790001137$pharmaceutical, 790001222$posterior pituitary, 790001363$Secreted, 790001405$signal]
oxytocin, prepropeptide,UP_SEQ_FEATURE[850034083$chain:Neurophysin 1, 850102883$disulfide bond, 850106258$modified residue, 850108604$peptide:Oxytocin, 850117294$sequence conflict, 850117814$signal peptide]
prostaglandin E receptor 4 (subtype EP4),BIOCARTA[30000093$h_eicosanoidPathway:Eicosanoid Metabolism]
prostaglandin E receptor 4 (subtype EP4),INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450001095$IPR001244:Prostaglandin DP receptor, 450001557$IPR001758:Prostanoid EP4 receptor, 450007643$IPR008365:Prostanoid receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
prostaglandin E receptor 4 (subtype EP4),KEGG_PATHWAY[470038833$hsa04080:Neuroactive ligand-receptor interaction]
prostaglandin E receptor 4 (subtype EP4),OMIM_DISEASE[520001992$Genome-wide assocation defines more than 30 distinct susceptibility loci for Crohn's disease, 520004766$Systematic association mapping identifies NELL1 as a novel IBD disease gene]
prostaglandin E receptor 4 (subtype EP4),PIR_SUPERFAMILY[630030090$PIRSF038586:prostaglandin E2 receptor EP4, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
prostaglandin E receptor 4 (subtype EP4),SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000574$G protein-coupled receptor, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001301$receptor, 790001546$transducer, 790001555$transmembrane, 790001556$transmembrane protein]
prostaglandin E receptor 4 (subtype EP4),UP_SEQ_FEATURE[850044714$chain:Prostaglandin E2 receptor EP4 subtype, 850102565$compositionally biased region:Poly-Ala, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
pumilio homolog 1 (Drosophila),INTERPRO[450001156$IPR001313:Pumilio RNA-binding region, 450010814$IPR011989:Armadillo-like helical]
pumilio homolog 1 (Drosophila),SMART[760000017$SM00025:Pumilio]
pumilio homolog 1 (Drosophila),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001304$repeat, 790001339$rna-binding, 790001551$translation regulation]
pumilio homolog 1 (Drosophila),UP_SEQ_FEATURE[850048937$chain:Pumilio homolog 1, 850102378$compositionally biased region:Ala-rich, 850102485$compositionally biased region:Gln-rich, 850102597$compositionally biased region:Ser-rich, 850105124$domain:PUM-HD, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850116868$repeat:Pumilio 1, 850116869$repeat:Pumilio 2, 850116870$repeat:Pumilio 3, 850116871$repeat:Pumilio 4, 850116872$repeat:Pumilio 5, 850116873$repeat:Pumilio 6, 850116874$repeat:Pumilio 7, 850116875$repeat:Pumilio 8, 850117294$sequence conflict, 850118574$splice variant, 850118624$turn]
ribosomal protein S6 kinase, 90kDa, polypeptide 2; hypothetical LOC100127984,BIOCARTA[30000180$h_mapkPathway:MAPKinase Signaling Pathway]
ribosomal protein S6 kinase, 90kDa, polypeptide 2; hypothetical LOC100127984,INTERPRO[450000618$IPR000719:Protein kinase, core, 450000836$IPR000961:AGC-kinase, C-terminal, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450014563$IPR016239:Ribosomal protein S6 kinase II, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related, 450016207$IPR017892:Protein kinase, C-terminal]
ribosomal protein S6 kinase, 90kDa, polypeptide 2; hypothetical LOC100127984,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038835$hsa04114:Oocyte meiosis, 470038842$hsa04150:mTOR signaling pathway, 470038876$hsa04720:Long-term potentiation, 470038877$hsa04722:Neurotrophin signaling pathway, 470038884$hsa04914:Progesterone-mediated oocyte maturation]
ribosomal protein S6 kinase, 90kDa, polypeptide 2; hypothetical LOC100127984,PIR_SUPERFAMILY[630000714$PIRSF000606:ribosomal protein S6 kinase II, 630000715$PIRSF000606:Ribsml_S6_kin_2]
ribosomal protein S6 kinase, 90kDa, polypeptide 2; hypothetical LOC100127984,SMART[760000115$SM00133:S_TK_X, 760000193$SM00220:S_TKc]
ribosomal protein S6 kinase, 90kDa, polypeptide 2; hypothetical LOC100127984,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000134$ATP, 790000138$atp-binding, 790000149$autophosphorylation, 790000356$complete proteome, 790000811$isopeptide bond, 790000825$kinase, 790000899$magnesium, 790000937$metal-binding, 790000983$monomer, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001168$phosphotransferase, 790001212$polymorphism, 790001304$repeat, 790001329$ribosomal protein, 790001388$serine/threonine-protein kinase, 790001390$serine/threonine-specific protein kinase, 790001547$transferase, 790001592$ubl conjugation]
ribosomal protein S6 kinase, 90kDa, polypeptide 2; hypothetical LOC100127984,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850057901$chain:Ribosomal protein S6 kinase alpha-2, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850103028$domain:AGC-kinase C-terminal, 850105087$domain:Protein kinase 1, 850105088$domain:Protein kinase 2, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
ring finger protein 8,INTERPRO[450000219$IPR000253:Forkhead-associated, 450001628$IPR001841:Zinc finger, RING-type, 450015659$IPR017335:E3 ubiquitin ligase, RNF8, 450016222$IPR017907:Zinc finger, RING-type, conserved site, 450017227$IPR018957:Zinc finger, C3HC4 RING-type]
ring finger protein 8,PIR_SUPERFAMILY[630029522$PIRSF037950:E3 ubiquitin-protein ligase RNF8, 630029523$PIRSF037950:E3_ubiquit_lig_RNF8]
ring finger protein 8,SMART[760000158$SM00184:RING, 760000212$SM00240:FHA]
ring finger protein 8,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000258$cell cycle, 790000260$cell division, 790000311$chromatin regulator, 790000315$chromosomal protein, 790000356$complete proteome, 790000452$DNA damage, 790000459$dna repair, 790000859$ligase, 790000937$metal-binding, 790000973$mitosis, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001592$ubl conjugation, 790001593$ubl conjugation pathway, 790001648$zinc, 790001651$zinc-finger]
ring finger protein 8,UP_SEQ_FEATURE[850016728$chain:E3 ubiquitin-protein ligase RNF8, 850102485$compositionally biased region:Gln-rich, 850103775$domain:FHA, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118911$zinc finger region:RING-type]
scribbled homolog (Drosophila),COG_ONTOLOGY[90000070$Function unknown]
scribbled homolog (Drosophila),INTERPRO[450001316$IPR001478:PDZ/DHR/GLGF, 450001429$IPR001611:Leucine-rich repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype]
scribbled homolog (Drosophila),SMART[760000200$SM00228:PDZ, 760000333$SM00369:LRR_TYP]
scribbled homolog (Drosophila),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000263$cell junction, 790000264$cell membrane, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790000434$differentiation, 790000853$leucine-rich repeat, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001592$ubl conjugation]
scribbled homolog (Drosophila),UP_SEQ_FEATURE[850047620$chain:Protein scribble homolog, 850102507$compositionally biased region:Glu-rich, 850102586$compositionally biased region:Pro-rich, 850104919$domain:PDZ 1, 850104924$domain:PDZ 2, 850104925$domain:PDZ 3, 850104926$domain:PDZ 4, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850112093$region of interest:Interaction with ARHGEF7, 850114817$region of interest:Sufficient for targeting to adherens junction and to inhibit cell proliferation, 850116308$repeat:LRR 1, 850116309$repeat:LRR 10, 850116310$repeat:LRR 11, 850116311$repeat:LRR 12, 850116312$repeat:LRR 13, 850116313$repeat:LRR 14, 850116314$repeat:LRR 15, 850116315$repeat:LRR 16, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850116346$repeat:LRR 9, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand]
sialic acid binding Ig-like lectin 10,INTERPRO[450002642$IPR003006:Immunoglobulin/major histocompatibility complex, conserved site, 450003159$IPR003598:Immunoglobulin subtype 2, 450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011750$IPR013106:Immunoglobulin V-set, 450011788$IPR013151:Immunoglobulin, 450011799$IPR013162:CD80-like, immunoglobulin C2-set]
sialic acid binding Ig-like lectin 10,SMART[760000356$SM00408:IGc2, 760000357$SM00409:IG]
sialic acid binding Ig-like lectin 10,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000256$cell adhesion, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000848$Lectin, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001555$transmembrane]
sialic acid binding Ig-like lectin 10,UP_SEQ_FEATURE[850000550$binding site:Sialic acid, 850060683$chain:Sialic acid-binding Ig-like lectin 10, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104378$domain:Ig-like C2-type 3, 850104407$domain:Ig-like V-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850117520$short sequence motif:ITIM motif 1, 850117521$short sequence motif:ITIM motif 2, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
solute carrier family 39 (metal ion transporter), member 5,INTERPRO[450003234$IPR003689:Zinc/iron permease]
solute carrier family 39 (metal ion transporter), member 5,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000616$glycoprotein, 790000798$ion transport, 790000919$membrane, 790001405$signal, 790001555$transmembrane, 790001558$transport, 790001648$zinc, 790001650$zinc transport]
solute carrier family 39 (metal ion transporter), member 5,UP_SEQ_FEATURE[850102287$chain:Zinc transporter ZIP5, 850105770$glycosylation site:N-linked (GlcNAc...), 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
solute carrier family 8 (sodium/calcium exchanger), member 3,INTERPRO[450003190$IPR003644:Na-Ca exchanger/integrin-beta4, 450004315$IPR004836:Sodium/calcium exchanger protein, 450004316$IPR004837:Sodium/calcium exchanger membrane region]
solute carrier family 8 (sodium/calcium exchanger), member 3,KEGG_PATHWAY[470038829$hsa04020:Calcium signaling pathway]
solute carrier family 8 (sodium/calcium exchanger), member 3,PIR_SUPERFAMILY[630012329$PIRSF015579:human Na+/Ca2+-exchanging protein]
solute carrier family 8 (sodium/calcium exchanger), member 3,SMART[760000209$SM00237:Calx_beta]
solute carrier family 8 (sodium/calcium exchanger), member 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000102$antiport, 790000211$calcium, 790000215$calcium transport, 790000218$calmodulin-binding, 790000356$complete proteome, 790000616$glycoprotein, 790000798$ion transport, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001418$Sodium, 790001421$Sodium transport, 790001555$transmembrane, 790001558$transport]
solute carrier family 8 (sodium/calcium exchanger), member 3,UP_SEQ_FEATURE[850061255$chain:Sodium/calcium exchanger 3, 850103247$domain:Calx-beta 1, 850103258$domain:Calx-beta 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850111164$region of interest:Calmodulin-binding, 850115628$repeat:Alpha-1, 850115629$repeat:Alpha-2, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
suppression of tumorigenicity 7,INTERPRO[450006676$IPR007311:ST7]
suppression of tumorigenicity 7,PIR_SUPERFAMILY[630011303$PIRSF013653:Caenorhabditis elegans hypothetical protein F11A10.5]
suppression of tumorigenicity 7,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
suppression of tumorigenicity 7,UP_SEQ_FEATURE[850063011$chain:Suppressor of tumorigenicity 7 protein, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
thyroid adenoma associated,INTERPRO[450017680$IPR019442:Protein of unknown function DUF2428, death-receptor-like]
thyroid adenoma associated,OMIM_DISEASE[520003247$Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes]
thyroid adenoma associated,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000316$chromosomal rearrangement, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor]
thyroid adenoma associated,UP_SEQ_FEATURE[850064453$chain:Thyroid adenoma-associated protein, 850102565$compositionally biased region:Poly-Ala, 850102576$compositionally biased region:Poly-Leu, 850102577$compositionally biased region:Poly-Lys, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
trinucleotide repeat containing 6C,INTERPRO[450000382$IPR000449:Ubiquitin-associated/translation elongation factor EF1B, N-terminal, 450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait, 450014352$IPR015940:Ubiquitin-associated/translation elongation factor EF1B, N-terminal, eukaryote, 450017723$IPR019486:Argonaute hook]
trinucleotide repeat containing 6C,SMART[760000144$SM00165:UBA, 760000328$SM00360:RRM]
trinucleotide repeat containing 6C,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001339$rna-binding, 790001342$rna-mediated gene silencing, 790001551$translation regulation]
trinucleotide repeat containing 6C,UP_SEQ_FEATURE[850066614$chain:Trinucleotide repeat-containing gene 6C protein, 850102517$compositionally biased region:Gly-rich, 850102565$compositionally biased region:Poly-Ala, 850102586$compositionally biased region:Pro-rich, 850102605$compositionally biased region:Thr-rich, 850105211$domain:RRM, 850105597$domain:UBA, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850114746$region of interest:Sufficient for interaction with argonaute family proteins, 850114820$region of interest:Sufficient for translational repression when tethered to a target mRNA, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
tripartite motif-containing 8,INTERPRO[450001628$IPR001841:Zinc finger, RING-type, 450016222$IPR017907:Zinc finger, RING-type, conserved site, 450017227$IPR018957:Zinc finger, C3HC4 RING-type]
tripartite motif-containing 8,SMART[760000158$SM00184:RING]
tripartite motif-containing 8,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000937$metal-binding, 790001304$repeat, 790001648$zinc, 790001651$zinc-finger]
tripartite motif-containing 8,UP_SEQ_FEATURE[850066677$chain:Tripartite motif-containing protein 8, 850117294$sequence conflict, 850118639$zinc finger region:B box-type 1, 850118642$zinc finger region:B box-type 2, 850118911$zinc finger region:RING-type]
uroplakin 1A,INTERPRO[450000259$IPR000301:Tetraspanin, subgroup, 450016772$IPR018499:Tetraspanin]
uroplakin 1A,PIR_SUPERFAMILY[630005687$PIRSF005764:uroplakin]
uroplakin 1A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
uroplakin 1A,UP_SEQ_FEATURE[850099669$chain:Uroplakin-1a, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
zinc finger protein 513,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 513,INTERPRO[450006475$IPR007087:Zinc finger, C2H2-type, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 513,SMART[760000323$SM00355:ZnF_C2H2]
zinc finger protein 513,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 513,UP_SEQ_FEATURE[850101704$chain:Zinc finger protein 513, 850102517$compositionally biased region:Gly-rich, 850102572$compositionally biased region:Poly-Glu, 850117294$sequence conflict, 850118574$splice variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8]
zinc finger protein 665,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 665,INTERPRO[450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 665,SMART[760000323$SM00355:ZnF_C2H2]
zinc finger protein 665,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 665,UP_SEQ_FEATURE[850101837$chain:Zinc finger protein 665, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118656$zinc finger region:C2H2-type 1, 850118657$zinc finger region:C2H2-type 10, 850118660$zinc finger region:C2H2-type 11, 850118663$zinc finger region:C2H2-type 12, 850118666$zinc finger region:C2H2-type 13, 850118669$zinc finger region:C2H2-type 14, 850118671$zinc finger region:C2H2-type 15, 850118674$zinc finger region:C2H2-type 16, 850118676$zinc finger region:C2H2-type 17, 850118679$zinc finger region:C2H2-type 18, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8, 850118737$zinc finger region:C2H2-type 9]
zinc finger, MYND domain containing 11,INTERPRO[450000267$IPR000313:PWWP, 450001324$IPR001487:Bromodomain, 450001628$IPR001841:Zinc finger, RING-type, 450001740$IPR001965:Zinc finger, PHD-type, 450002557$IPR002893:Zinc finger, MYND-type, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
zinc finger, MYND domain containing 11,SMART[760000158$SM00184:RING, 760000221$SM00249:PHD, 760000264$SM00293:PWWP, 760000267$SM00297:BROMO]
zinc finger, MYND domain containing 11,SP_PIR_KEYWORDS[790000206$bromodomain, 790000258$cell cycle, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger, MYND domain containing 11,UP_SEQ_FEATURE[850101422$chain:Zinc finger MYND domain-containing protein 11, 850103166$domain:Bromo, 850105126$domain:PWWP, 850106258$modified residue, 850114256$region of interest:Required for binding to E1A, 850117610$short sequence motif:Nuclear localization signal, 850118853$zinc finger region:MYND-type, 850118877$zinc finger region:PHD-type]
